New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
08:08 EDTMNTAMomenta Pharma stills sees 2013 operating cash use about $90M
Momenta confirmed its guidance, previously provided in November, for total operating expenses, excluding stock-based compensation and net of collaborative revenues, of approximately $30M per quarter in 2013. For 2013, Momenta is projecting that its net cash usage will average approximately $20M-$24M per quarter for a total operating cash usage of approximately $90M.
News For MNTA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
15:38 EDTMNTAMomenta announces results from preclinical studies on hsIVIg program published
Momenta Pharmaceuticals announced that results from preclinical studies on its hyper-sialylated IVIg, or hsIVIg, program were published in this week's Early Edition of Proceedings of the National Academy of Sciences. The article summarizes Momenta's progress in creating a hsIVIg drug candidate with the potential for more consistent and enhanced anti-inflammatory activity compared to the current IVIg therapy used to treat inflammatory and autoimmune diseases.
10:02 EDTMNTAHigh option volume stocks
High option volume stocks: MNTA NTRI KOS NST GSAT THC CHL MSI CAKE NXPI
09:34 EDTMNTAActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL MNTA CELG TSLA MCD ARUN GILD KO TWTR NFLX
February 23, 2015
06:32 EDTMNTAMomenta enters $75M At-The-Market equity sales agreement with Stifel
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use